Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.503 USD | -1.76% | +6.22% | -31.37% |
Feb. 14 | Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 14 | Transcript : Aethlon Medical, Inc., Q3 2024 Earnings Call, Feb 14, 2024 |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.01M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -13M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.29
x | P/E ratio 2025 * |
-0.43
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.56% |
Latest transcript on Aethlon Medical, Inc.
1 day | -1.76% | ||
1 week | +6.22% | ||
Current month | -10.54% | ||
1 month | -13.62% | ||
3 months | -21.70% | ||
6 months | +0.87% | ||
Current year | -31.37% |
Managers | Title | Age | Since |
---|---|---|---|
James Frakes
CEO | Chief Executive Officer | 67 | 08-01-08 |
Lee Arnold
CTO | Chief Tech/Sci/R&D Officer | 64 | - |
Guy Cipriani
COO | Chief Operating Officer | 54 | 18-06-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Frakes
CEO | Chief Executive Officer | 67 | 08-01-08 |
Chairman | 88 | 99-03-09 | |
Guy Cipriani
COO | Chief Operating Officer | 54 | 18-06-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.503 | -1.76% | 544 |
24-04-24 | 1.53 | +1.20% | 619 |
24-04-23 | 1.512 | +2.16% | 17,053 |
24-04-22 | 1.48 | +1.37% | 1,438 |
24-04-19 | 1.46 | +3.18% | 18,493 |
Delayed Quote Nasdaq, April 25, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.37% | 4.01M | |
+7.71% | 220B | |
+6.25% | 185B | |
+10.60% | 133B | |
+26.73% | 107B | |
-0.57% | 62.91B | |
+15.42% | 53.34B | |
-1.89% | 47.71B | |
-1.91% | 40.29B | |
+11.16% | 39.57B |
- Stock Market
- Equities
- AEMD Stock